Your browser doesn't support javascript.
loading
Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.
Sakai, Makoto; Sohda, Makoto; Saito, Hideyuki; Kuriyama, Kengo; Yoshida, Tomonori; Kumakura, Yuji; Hara, Keigo; Yokobori, Takehiko; Miyazaki, Tatsuya; Murata, Kazutoshi; Noda, Shin-Ei; Nakano, Takashi; Kuwano, Hiroyuki; Shirabe, Ken.
Afiliación
  • Sakai M; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Sohda M; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. msohda@gunma-u.ac.jp.
  • Saito H; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Kuriyama K; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Yoshida T; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Kumakura Y; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Hara K; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Yokobori T; Department of Innovative Cancer Immunotherapy, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Miyazaki T; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Murata K; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Noda SE; Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Nakano T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Kuwano H; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
  • Shirabe K; Fukuoka City Hospital, Fukuoka, Japan.
Cancer Chemother Pharmacol ; 83(6): 1121-1126, 2019 06.
Article en En | MEDLINE | ID: mdl-30972455
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Radioterapia de Intensidad Modulada Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Radioterapia de Intensidad Modulada Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article